Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment
Key facts
- Where
- Atlanta, Chicago, Gainesville, New York, and Palo Alto, United StatesSee the 6 sites
Where in United States
- Children's Healthcare of AtlantaAtlanta, United StatesContact: Fawwaz Shaw, MDTaking people
- Lurie Children's HospitalChicago, United StatesContact: Michael Monge, MDTaking people
- University of FloridaGainesville, United StatesContact: Jeffrey Jacobs, MDTaking people
- Columbia UniversityNew York, United StatesContact: Kanwal Farooqi, MDTaking people
- Weill CornellNew York, United StatesContact: Yoshifumi Naka, MDNot yet recruiting
- Stanford UniversityPalo Alto, United StatesContact: Sujatha Buddhe, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Columbia University
- Trial code
- NCT03891160
- Record updated
- 23 October 2026
- Original description
The purpose of this research study is to look at the advantages of using a 3D printed heart model for surgical planning in children who have been diagnosed with Congenital Heart Disease (CHD) and clinical heart failure and will undergo a ventricular assist device (VAD) placement. The investigators want to study the correlation of having a 3D printed model with improvement in patient outcomes and compare those with patients who have had a VAD placement without a 3D model.Read full original descriptionShow less
The purpose of this research study is to look at the advantages of using a 3D printed heart model for surgical planning in children who have been diagnosed with Congenital Heart Disease (CHD) and clinical heart failure and will undergo a ventricular assist device (VAD) placement. The investigators want to study the correlation of having a 3D printed model with improvement in patient outcomes and compare those with patients who have had a VAD placement without a 3D model.
Inclusion: Patients who weigh over 3 kilograms with CHD HF who are candidates for MCS will be prospectively identified at the participating centers.
Exclusion: Any CHD-HF patient unable to tolerate a CMR or cardiac CT will be excluded.